Oxidativestress isinitiated by the presence of a reactive oxygen
species (ROS) which the cell fails to counterbalance and then it
damages the biomolecules such as DNA, RNA, lipids and proteins.
Oxidative stress has been associated with the aging process as well
as various other disease states.It is an ongoingprocess between
highly reactive radicals and the body system designed for mitigating
their effects.Few diseases occur from a failure to counter these
effects. Oxidative stress causes many pathophysiological disorders in
the body and some of these include neurodegenerative diseases such as
Alzheimer’s disease and Parkinson's disease, cancers, fragile X
syndrome, chronic fatigue syndrome, atherosclerosis, heart and blood
vessel disorders, cardiovascular disease, inflammatory diseases and
others.Oxidative stress assay is a method for detecting and screening
markers of oxidative stress in cells. It is a great tool for
analyzing and evaluating the capacity to counter the oxidative stress
as it provides relevant biological information.
Furthermore, progresses are made in the field of oxidative stress
assay markets are technologically advanced equipment with updated
technologies to produce high efficiency and accuracy in the testing
of oxidative stress.Rapid growth in the pharmaceutical and
biotechnological industry, robust trend of research and development,
investments in the healthcare sectors, up gradation oftechnology such
as content screening for drug discovery, and government subsidy for
life science research are the prime growth drivers for oxidative
stress assay market. However, there are fewhindrances in the growth
of the market; these arelack of awareness, emerging technologies,
increased cost of instruments and lack of qualified professionals.
The oxidative stress assay market can be segmented as products, test
types, technologies, end users and disease type.
Product types of oxidative stress assay market are divided on the
basis of consumables and instruments. Consumables arecategorized as
kits and reagents, buffers and chemicals, microplates and antibodies
and reagents. The consumables segment in the product type is largest
inthe market and is expected to grow at the fastest rate in near
future. The main reason for it are clinical advances and increased
use incontract research organizations (CRO) and biotechnological
industries.
Request a Brochure of the Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8446
The test type can be divided as reactive oxygen species (ROS)-based
assays and enzyme-based assays, antioxidant capacity assays.
Based ontechnologies the market is divided as ELISA, chromatography
and microscopy.
Oxidative stress assay market can be broadly divided into disease
types such as cardiovascular disease, diabetes, chronic obstructive
pulmonary disease (COPD), cancer and asthma.
The end users for oxidative stress assay market are categorized as
clinical laboratories, pharmaceutical companies, contract research
organizations (CRO) and biotechnological companies.
Geographically the market for oxidative stress assay market are
divided as North America, Europe, Asia Pacific, Latin America and
Rest of the world.There are some major reasons, responsible for their
dominance in this market are increasing number of aged population and
high levels of public awareness and innovative technologies. North
America and Europe are in the leading position in this market due to
their highly advanced technology and infrastructure compared to the
improving infrastructure in emerging regions. However, Asia Pacific
is estimatedto grow in oxidative stress assay market in future for
number of factors such as government initiatives, growing awareness
and increased investment in healthcare sector.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=8446
Some of the key players in the oxidative stress assay marketbased on
pharmaceutical and biotechnological companies are Abcam Plc.,
BioVision, Inc., Cell Biolabs, Inc., Merck and Co., Inc., Oxford
Biomedical Research, Promega Corporation,Sigma-Aldrich Corporation
and Thermo Fisher Scientific, Inc., while the leading clinical
laboratories are Alliance Imaging, Inc., Array BioPharma Inc.,
Genoptix, Inc. and Quest Diagnostics.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment